NM_018029.4:c.172A>G

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_018029.4(EBLN2):​c.172A>G​(p.Ser58Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000207 in 1,447,800 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000021 ( 0 hom. )

Consequence

EBLN2
NM_018029.4 missense

Scores

2
17

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.347

Publications

0 publications found
Variant links:
Genes affected
EBLN2 (HGNC:25493): (endogenous Bornavirus like nucleoprotein 2)
PPP4R2 (HGNC:18296): (protein phosphatase 4 regulatory subunit 2) The protein encoded by this gene is a regulatory subunit of the serine/threonine-protein phosphatase 4 complex. In addition to being required for efficient DNA double strand break repair, this complex plays a role in organization of microtubules at centrosomes and processing of spliceosomal snRNPs. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2015]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.13009638).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
EBLN2NM_018029.4 linkc.172A>G p.Ser58Gly missense_variant Exon 1 of 1 ENST00000533473.1 NP_060499.3 Q6P2I7
PPP4R2NM_174907.4 linkc.419+1193A>G intron_variant Intron 5 of 8 ENST00000356692.10 NP_777567.1 Q9NY27-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
EBLN2ENST00000533473.1 linkc.172A>G p.Ser58Gly missense_variant Exon 1 of 1 6 NM_018029.4 ENSP00000432104.1 Q6P2I7
PPP4R2ENST00000356692.10 linkc.419+1193A>G intron_variant Intron 5 of 8 1 NM_174907.4 ENSP00000349124.5 Q9NY27-1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
0.00000207
AC:
3
AN:
1447800
Hom.:
0
Cov.:
62
AF XY:
0.00000139
AC XY:
1
AN XY:
720068
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00
AC:
0
AN:
32382
American (AMR)
AF:
0.00
AC:
0
AN:
39716
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25624
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39604
South Asian (SAS)
AF:
0.00
AC:
0
AN:
83464
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53210
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5728
European-Non Finnish (NFE)
AF:
0.00000271
AC:
3
AN:
1108242
Other (OTH)
AF:
0.00
AC:
0
AN:
59830
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.076386), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.392
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32
Alfa
AF:
0.00
Hom.:
0

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Mar 17, 2023
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.172A>G (p.S58G) alteration is located in exon 1 (coding exon 1) of the EBLN2 gene. This alteration results from a A to G substitution at nucleotide position 172, causing the serine (S) at amino acid position 58 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Benign
-0.23
T
BayesDel_noAF
Benign
-0.57
CADD
Benign
13
DANN
Benign
0.94
DEOGEN2
Benign
0.0091
T
Eigen
Benign
-0.84
Eigen_PC
Benign
-1.0
FATHMM_MKL
Benign
0.022
N
LIST_S2
Benign
0.21
T
M_CAP
Benign
0.0019
T
MetaRNN
Benign
0.13
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.0
N
PhyloP100
0.35
PrimateAI
Benign
0.44
T
PROVEAN
Benign
-2.0
N
REVEL
Benign
0.021
Sift
Pathogenic
0.0
D
Sift4G
Pathogenic
0.0
D
Polyphen
0.81
P
Vest4
0.12
MutPred
0.30
Gain of glycosylation at S55 (P = 0.0054);
MVP
0.081
MPC
0.0060
ClinPred
0.19
T
GERP RS
0.23
Varity_R
0.26
gMVP
0.0050
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1702877387; hg19: chr3-73111404; API